Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Elosulfase alfa

(Synonyms: Chondrosulfatases, Chondrosulfatase, Chondroitin sulfatase, BMN 110) Copy Product Info
🥰Excellent

Synonyms: Chondrosulfatases, Chondrosulfatase, Chondroitin sulfatase, BMN 110

Catalog No. T82477 Copy Product Info
🥰Excellent
Elosulfase alfa (BMN 110), a recombinant human N-acetylgalactosamine-6-sulfatase (GALNS), serves as enzyme replacement therapy for mucopolysaccharidosis IVA (MPS IVA), commonly referred to as Morquio A syndrome [1].
Elosulfase alfa
Cas No. 9025-60-9
Pack SizePriceUSA StockGlobal StockQuantity
1 mgInquiry4-6 weeks4-6 weeks
5 mgInquiry4-6 weeks4-6 weeks
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Elosulfase alfa (BMN 110), a recombinant human N-acetylgalactosamine-6-sulfatase (GALNS), serves as enzyme replacement therapy for mucopolysaccharidosis IVA (MPS IVA), commonly referred to as Morquio A syndrome [1].
SynonymsChondrosulfatases, Chondrosulfatase, Chondroitin sulfatase, BMN 110
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
TargetGALNS
Chemical Properties
Cas No.9025-60-9
Storage & Solubility Information
Storage-20°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion
Related Tags: